{"Clinical Trial ID": "NCT00328783", "Intervention": ["INTERVENTION 1:", "Active breathing coordinator", "\u2022 Patients breathe through the ABC device", "The active breathing coordinator (ABC): Dose distributions generated by free breathing plans relative to ABC will be compared to assess the normal tissue volume, as well as the irradiated target volume, using dose-volume histograms."], "Eligibility": ["Incorporation criteria:", "\u2022 Requires adjuvant or post-mastectomy radiation therapy with tangential fields or 3 fields", "Adequate pulmonary function", "5 cc of heart or liver with simulation fields", "Karnofsky Performance Status (KPS) equal to or greater than 70", "- Exclusion criteria:", "Pregnant women", "Patients who have previously received ipsilateral radiotherapy in the breast or chest"], "Results": ["Performance measures:", "Dosimetric assessment Extent of irradiated normal tissue reduction", "To assess the extent of the reduction of normal irradiated tissues (heart and lung) when using the active breathing coordinator (ABC) in breast patients, compared to normal, free breathing.", "The dose distributions generated by free respiration plans against ABC will be compared to assess the normal tissue volume, as well as the irradiated target volume, using dose-volume histograms. Specifically, for the heart, the volume receiving 55 and 40 Gy will be evaluated; for the liver, the volume receiving 50 and 36 Gy, and for the lung, the volume receiving 20 Gy. For the contralateral breast, the volume receiving 20 Gy, 30 Gy and 50 Gy will be evaluated. Patients will be treated with the ABC device if there is a relative reduction of at least 5% in the volume of normal irradiated tissue at the prescription dose.", "Time limit: at the time of cancellation", "Results 1:", "Title of the arm/group: Active breathing coordinator", "Description of the arm/group: Patients breathe through the ABC device", "The active breathing coordinator (ABC): Dose distributions generated by free breathing plans relative to ABC will be compared to assess the normal tissue volume, as well as the irradiated target volume, using dose-volume histograms.", "Total number of participants analysed: 86", "Average (95% confidence interval)", "Unit of measurement: Gy Free breathing (heart): 3.0 (2.6 to 3.3)", "- ABC (heart): 1.1 (0.9 to 1.3)", "Free breathing (lung): 6.0 (5.3 to 6.8)", "- ABC (lung): 5.4 (4.9 to 5.9)"], "Adverse Events": ["Undesirable Events 1:", "Total: 0/0"]}